February 22, 2021
Shaina Horner, a clinical researcher in the Division of Infectious Diseases used her connections in the local Latinx community to help recruit a diverse population for the Moderna COVID-19 vaccine trial.
February 3, 2021
UC pharmacy student participation in vaccine effort is moving the needle on getting Ohio's population immunized.
March 9, 2021
University of Cincinnati researchers have discovered that cooperation between two key genes drive cancer growth, spread and treatment resistance in one particularly aggressive type of breast cancer. The good news is, though, with this knowledge, they can continue to aim their targeted treatments at these genes, singularly and together, to stop breast cancer in its tracks.
March 16, 2021
UC-led reserach is looking for an alternative to direct eye injections for certain eye diseases such as maculardegeneration and diabetic retinaopathy.
December 11, 2020
Matthew de Gannes is one of 38 students in the College of Medicine who will earn degrees during the virtual 2020 fall commencement ceremonies set for Dec. 11 and 12. The college will grant 14 doctoral, 23 master’s and one bachelor’s degree. UC is awarding a total of 2,457 degrees to 2,348 students during fall commencement. Some UC programs allow students to earn dual degrees.
January 7, 2021
Research at the University of Cincinnati contends that remdesivir is being used too indiscriminately when treating patients hospitalized with the COVID-19..
March 29, 2020
The app HiLois, an invention of UC's Brett Harnett, is allowing senior citizens in assisted living facilities to connect with their families during quarantine. Forbes highlighted the technology.
April 22, 2020
Alvaro Puga is the winner of the 2020 George Rieveschl Award for Distinguished Scientific Research.
October 12, 2020
In one of the first studies of its kind, a University of Cincinnati researcher is using a grant from the Ohio attorney general’s office to research the pharmacogenomics of opioid addiction. The grant was awarded to Caroline Freiermuth, MD, associate professor in the Department of Emergency Medicine at the UC College of Medicine, the principal investigator for the study. The initial year will be supported with $1.63 million from the attorney general’s office, secured through money collected from pharmaceutical companies involved in opioid lawsuits. Pharmacogenomics, a relatively new field, is the study of how genes affect a person's response to drugs.